Sham neurofeedback for borderline personality disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 4 Oct 2024: Trial registered, NCT06626789
  2. 23 Apr 2025: Trial started, NCT06626789

The trials

NCT06626789: Brain Signal Training to Enhance Affect Down-regulation

State
Under way
Phase
Phase 1 and Phase 2
People
164 planned
Started
23 Apr 2025
Primary completion
Dec 2027
Arms
Control group
Results
None posted
  1. 4 Oct 2024: Trial registered
  2. 23 Apr 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.